The role of antibodies against the P/Q type voltage-gated calcium channels (VGCC-ab) in the pathogenesis of paraneoplastic cerebellar degeneration (PCD) and lung cancer is unclear. We evaluated in mice the effect of intrathecal injection of IgG purified from serum of a patient with both PCD and Lambert-Eaton myasthenic syndrome (LEMS), and from another patient with isolated LEMS. Mice injected with PCD/LEMS IgG developed marked, reversible ataxia compared with those injected with LEMS or control IgG. These findings suggest that P/Q-type VGCC-ab may play a role in the pathogenesis of ataxia in patients with PCD and SCLC.
Introduction
Paraneoplastic cerebellar degeneration (PCD) is one of the best characterized paraneoplastic neurological syndromes. Patients with PCD develop a subacute pancerebellar syndrome caused by severe loss of the Purkinje cells of the cerebellum (Graus et al., 2004) . Many of them harbor serum and cerebrospinal fluid (CSF) antibodies against different intracellular neuronal antigens depending on the type of underlying tumor that usually are breast, ovary, small-cell lung cancer (SCLC), and Hodgkin lymphoma (Shams'ili et al., 2003) . There is no evidence to support that these antibodies, called onconeural antibodies, are pathogenic because the antigen is intracellular and multiple attempts to produce an animal model by passive transfer of patients' IgG or vaccination with the antigens have failed (Graus et al., 1991; Carpentier et al., 1998) . Onconeural antibodies probably represent the humoral component of a more complex immune response, likely mediated by cytotoxic T-cell mechanisms against the same onconeural antigens eventually resulting in Purkinje cell death (Darnell and Posner, 2003) .
When PCD occurs in association with SCLC, patients develop two clinical-immunological features that are not seen in other tumor associations. First, up to 25% of patients with PCD and SCLC show clinical or neurophysiological features of Lambert-Eaton myasthenic syndrome (LEMS), and second, 50% of them harbor serum and CSF antibodies against P/Q type voltage-gated calcium channels (VGCC-ab) that are highly expressed in the cerebellum and neuromuscular junction (Mason et al., 1997; Graus et al., 2002) . The clinical features of LEMS, muscle weakness and autonomic dysfunction, are caused by the antibody binding to P/Q type VGCC at the presynaptic nerve terminals leading to a reduction in neurotransmitter release. However, the role of P/Q type VGCC-ab in the pathogenesis of PCD is unclear. One possibility is that patients with PCD and P/Q type VGCC-ab develop additional antibodies or T-cell mediated mechanisms that are responsible for the cerebellar symptoms. Alternatively, the P/Q type VGCC-ab of patients with PCD could differ from those found in LEMS in the capacity to alter Purkinje cell function. In the current study we determined if intrathecal injection of IgG from P/Q type VGCC-ab positive patients with SCLC and isolated paraneoplastic LEMS or PCD may produce cerebellar ataxia in mice. E-mail address: fgraus@clinic.ub.es (F. Graus). 1 Equally contributed to the study.
